These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 33909676)

  • 1. Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack-Protocol for a systematic review and network meta-analysis.
    Zitikyte G; Roy DC; Dhaliwal S; Lun R; Hutton B; Shorr R; Dowlatshahi D
    PLoS One; 2021; 16(4):e0250553. PubMed ID: 33909676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
    JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Dual Antiplatelet Therapies for Minor, Nondisabling, Acute Ischemic Stroke: A Bayesian Network Meta-Analysis.
    Lim A; Ma H; Ly J; Singhal S; Pan Y; Wang Y; Johnston SC; Phan TG
    JAMA Netw Open; 2024 May; 7(5):e2411735. PubMed ID: 38753327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
    Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
    BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis.
    Marinheiro G; Araújo B; Monteiro GA; Leite M; Mutarelli A; Almeida AM; Cavalcante-Neto JF; Rivera A; Pinheiro AC; Telles JPM
    J Neurol; 2024 Jun; 271(6):3030-3038. PubMed ID: 38580815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack.
    Medranda GA; Zhang C; Doros G; Yerasi C; Case BC; Weintraub WS; Waksman R
    Am J Cardiol; 2021 Aug; 153():129-134. PubMed ID: 34226040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis.
    Yang Y; Huang Z; Zhang X
    Medicine (Baltimore); 2021 Dec; 100(50):e27804. PubMed ID: 34918630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
    Hao Q; Tampi M; O'Donnell M; Foroutan F; Siemieniuk RA; Guyatt G
    BMJ; 2018 Dec; 363():k5108. PubMed ID: 30563866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Ticagrelor versus Aspirin and Clopidogrel for Stroke Prevention in Patients with Vascular Disease: A Systematic Review and Meta-Analysis.
    Ma X; Li D; Liu S; Chen Y; Zhong P
    Eur Neurol; 2023; 86(4):229-241. PubMed ID: 37068471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
    Wang Y; Chen W; Lin Y; Meng X; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Zhao X; Liu L; Lin J; Dong K; Jing J; Johnston SC; Wang D; Wang Y;
    BMJ; 2019 Jun; 365():l2211. PubMed ID: 31171523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric treatment with aspirin and ticagrelor is the most cost-effective strategy in patients with minor stroke or transient ischemic attack.
    Narasimhalu K; Chan J; Ang YK; De Silva DA; Tan KB
    Int J Stroke; 2024 Feb; 19(2):209-216. PubMed ID: 37679898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack.
    Li ZX; Xiong Y; Gu HQ; Fisher M; Xian Y; Johnston SC; Wang YJ
    Stroke; 2021 Jul; 52(7):2250-2257. PubMed ID: 34039032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial.
    Zhang XG; Zhu XQ; Xue J; Li ZZ; Jiang HY; Hu L; Yue YH
    BMJ Open; 2019 May; 9(5):e028595. PubMed ID: 31123001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet Therapy for Transient Ischemic Attack and Minor Stroke.
    Xiong Y; Bath PM
    Stroke; 2020 Nov; 51(11):3472-3474. PubMed ID: 32972314
    [No Abstract]   [Full Text] [Related]  

  • 16. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
    Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
    JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial.
    Xie X; Jing J; Meng X; Claiborne Johnston S; Bath PM; Li Z; Zhao X; Liu L; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
    Stroke; 2023 Sep; 54(9):2241-2250. PubMed ID: 37548009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
    JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Effects of Dual Antiplatelet Therapy or Aspirin Monotherapy after Acute Minor Ischemic Stroke or Transient Ischemic Attack, a Meta-Analysis.
    Condello F; Liccardo G; Ferrante G
    Curr Pharm Des; 2021; 27(40):4140-4146. PubMed ID: 34323179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
    Liu X; Lv X; Peng Y; Wang J; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L
    BMC Neurol; 2024 Mar; 24(1):81. PubMed ID: 38429754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.